A detailed history of Advisor Net Financial, Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Advisor Net Financial, Inc holds 18 shares of TXG stock, worth $284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 45 60.0%
Holding current value
$284
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$15.71 - $23.49 $424 - $634
-27 Reduced 60.0%
18 $0
Q2 2024

Jul 16, 2024

BUY
$19.45 - $37.37 $875 - $1,681
45 New
45 $0
Q4 2022

Jan 13, 2023

BUY
$24.4 - $41.3 $244 - $413
10 New
10 $0
Q2 2022

Jul 07, 2022

SELL
$36.95 - $82.41 $369 - $824
-10 Reduced 66.67%
5 $0
Q1 2022

Apr 14, 2022

BUY
$55.7 - $145.79 $835 - $2,186
15 New
15 $1,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.